Clinical Trials Logo

Filter by:
NCT ID: NCT05939817 Completed - Keloid Clinical Trials

The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial

Start date: October 1, 2021
Phase: Phase 4
Study type: Interventional

The objective of this study is to observe the potency of umbilical cord-derived mesenchymal stem cells (UC-MSC) and umbilical cord-derived conditioned medium (UC-CM), or triamcinolone acetonide (TA) in keloid therapy, measured by the decrease in the type 1:3 collagen ratio and the increase of IL-10 levels carried out using CONSORT statement.

NCT ID: NCT05925829 Completed - Clinical trials for Diabetes Mellitus, Type 2

Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes

Start date: January 1, 2017
Phase: Phase 1
Study type: Interventional

This study was a retrospective study on type 2 diabetes patients that were treated with autologous stromal vascular fraction (SVF) and autologous activated platelet-rich plasma (aaPRP) measuring HbA1c level at baseline, 1-month, 3-month, 6-month, and 12-month post-treatment.

NCT ID: NCT05925647 Completed - Clinical trials for Rheumatoid Arthritis

The Effects of Mesenchymal Stem Cell Secretome in Rheumatoid Arthritis Patients

Start date: August 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This research is a clinical trial of administering mesenchymal stem cell secretome to rheumatoid arthritis patients.

NCT ID: NCT05921058 Completed - Lupus Erythematosus Clinical Trials

The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients

Start date: August 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This research is a clinical trial of administering mesenchymal stem cell secretome to lupus patients.

NCT ID: NCT05897892 Completed - Clinical trials for Nutrition Disorders in Old Age

The Clinical Study on the Mangrove Sword Bean Food Bar Effect for Older People

FF
Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical study is to assess the api-api mangrove sword bean food bar effect on the older people's weight affected by a landslide The main questions aimed to answer are: - Can api-api mangrove sword bean food bar improve the weight of older people affected by landslide? - Can balanced nutrition education increase the older peoples' knowledge? Participants divided in the two groups i.e.: - Treatment group received 50 g mangrove sword bean food bar each day during 15 days. - Control group received 50 g sword bean food bar each day during 15 days. - Both groups obtained balanced nutrition of older people education once at the first week of study.

NCT ID: NCT05889819 Completed - Clinical trials for Nutritional Stunting

Orange Almond Potato Cookies Supplementation

CS
Start date: January 5, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to assess the effect of potato almond orange cookie supplementation on the nutritional status of stunted under-five children. The main questions aimed to answer are: - Can cookie supplementation improve the weight of stunted under-five children? - Can cookie supplementation improve the weight for age z score of stunted under-five children? Participants divided in the two groups i.e.: - Treatment group received 50 g potato almond orange cookie each day during 4 weeks. - Control group received 50 g potato orange cookie each day during 4 weeks. - Mothers of both groups given balanced nutrition education for stunted under-five children twice at the second and third week of study.

NCT ID: NCT05887804 Completed - Keloid Clinical Trials

Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial

Start date: October 1, 2021
Phase: Phase 4
Study type: Interventional

This study is a double-blind randomized controlled trial (RCT) examining the effect of intralesional injection of umbilical cord-derived mesenchymal stem cells (UC-MSC), umbilical cord-derived conditioned medium (UC-CM), or triamcinolone acetonide (TA) on keloids carried out using CONSORT statement. Research is directed at studying keloid volume reduction and changes in POSAS score.

NCT ID: NCT05878886 Completed - Nutrition Poor Clinical Trials

Mangrove-sword Bean-food Bar on the Weight and Weight for Age Z Score of Under-five Children

MFB
Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to assess the effect of the food bar made from api-api mangrove (Avicennia marina) and sword bean (Canavalia ensiformis) blends on the weight and Weight-for-Age Z score affected by a landslide disaster. The main questions aimed to answer are: - Food bar supplementation can effect the weight and WAZ score of under-five children affected by landslides disaster? - Balanced nutrition education can increase the mothers' knowledge on the balanced nutrition of under-five children? Participants divided in to two group i.e.: - Treatment/intervention group consumed 50 g mangrove sword bean food bar each day during 15 days. - Control group consumed 50 g sword bean food bar each day during 15 days. - Each group received balanced nutrition for mothers once at the first week of study.

NCT ID: NCT05871645 Completed - Placenta Accreta Clinical Trials

Placenta Accreta Spectrum Management: Uterine Preservation Using JSICA Technique - Retrospective Cross-Sectional Study

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

The goal of this study is to present the Jakarta Surgical Uterine Conservation (JSICA) technique and its perioperative outcomes in Placenta Accreta Spectrum patients. Participants are all patients undergoing standard hysterectomy or the Jakarta Surgical Uterine Conservation (JSICA) technique. Researchers will compare both groups to see if there are any differences in the perioperative outcomes.

NCT ID: NCT05869383 Completed - Sarcopenia Clinical Trials

Effect Of Ophiochepalus Striatus Extract On Serum IGF-1 And IL-6 Levels In Elderly Patients With Sarcopenia

Start date: May 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this Clinical Trial is to analyze effect of Ophiochepalus striatus extract on serum IGF-1 and IL-6 levels in elderly patients with sarcopenia. The main questions it aims to answer are: 1. Can giving Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks increase IGF-1 levels in elderly people with sarcopenia? 2. Can administration of 2x5 grams dose of Ophiocephalus striatus extract for 2 weeks reduce IL-6 levels in elderly with sarcopenia? 3. Can the administration of Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks reduce the SARC-F score in elderly people with sarcopenia? 4. Can the administration of Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks increase muscle mass in elderly people with sarcopenia? 5. Can the administration of Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks increase muscle strength in elderly people with sarcopenia? 6. Can administration of Ophiocephalus striatus extract at a dose of 2x5 grams for 2 weeks improve physical performance in elderly with sarcopenia? Participants will: 1. Consume Ophiochepalus striatus extract 2x5 grams a day. 2. Checked blood before and after the intervention. 3. Measured muscle mass, muscle strength, and physical performance before and after the intervention.